Frederick Killion

This profile gathers the share dealings of Frederick Killion in Barr Pharmaceuticals Inc. In total, 4 filings cover trades dated from 14 February 2006 to 23 December 2008.

The open-market record consists of 1 sale worth €2.2M, with no purchase. Outside the open market, there are 2 share grants.

On 29 December 2008 came the latest disclosure, a transaction in Barr Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.